FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:819-820 September 12, 1996 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Miller, G. PubMed Citation

To the Editor: The report by Miller et al. (May 16 issue)¹ on the development of a serologic test for Kaposi's sarcoma–associated herpeslike virus (KSHV) is an important initial step in determining the potential causative role of this new agent in Kaposi's sarcoma. Two aspects of their epidemiologic analysis, however, are questionable. First, the results in the convenience sample of 48 patients with human immunodeficiency virus (HIV) infection and Kaposi's sarcoma and 54 HIV-infected patients without Kaposi's sarcoma are stated in terms of predictive values. Presumably, the authors are considering the use of the serologic marker as a diagnostic test. . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E. (2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev. 15: 439-464 [Abstract] [Full Text]  
• Martin, J. N., Ganem, D. E., Osmond, D. H., Page-Shafer, K. A., Macrae, D., Kedes, D. H. (1998). Sexual Transmission and the Natural History of Human Herpesvirus 8 Infection. NEJM 338: 948-954 [Abstract] [Full Text]